Project Covalence
Almost every company and non-profit working on COVID-19 that I offered to help asked for support with clinical trials—for companies focusing on developing novel drugs, vaccines, and diagnostics, rapidly spinning up trials is one of their biggest bottlenecks....
Almost every company and non-profit working on COVID-19 that I offered to help asked for support with clinical trials—for companies focusing on developing novel drugs, vaccines, and diagnostics, rapidly spinning up trial
Original source
Read the original post on Sam Altman's blog- Published
- 2020-06-16
- Updated
- 2026-02-23
- Words
- 242
- Reading time
- 2 min
https://blog.samaltman.com/project-covalence
Related Posts
Productivity
I think I am at least somewhat more productive than average, and people sometimes ask me for productivity tips. So I decided to just write them all down in one place. Compound growth gets discussed as a financial concept, but it works in careers as well, and it is magic....
US Digital Currency
I am pretty sure cryptocurrency is here to stay in some form (at least as a store of value, which is the only use case we have seen work at scale so far). There was possibly a time when governments could have totally stopped it, but it feels like that’s in the rearview mirror....
PG and Jessica
A lot of people want to replicate YC in some other industry or some other place or with some other strategy. In general, people seem to assume that: 1) although there was some degree of mystery or luck about how YC got going, it can’t be that hard, and 2) if y...
DALL•E 2
Today we did a research launch of DALL•E 2, a new AI tool that can create and edit images from natural language instructions. Most importantly, we hope people love the tool and find it useful. For me, it’s the most delightful thing to play with we’ve created so far....